Shares of Accelerate Diagnosti
(AXDX) are trading 8% higher at a price of $3.43 at the time of this writing. So far the Health Care sector has been having a slightly melancholic day, and the share price of the company is surpassing it's peers.
The share price is most likely rising on a strong earnings report 2 days ago. The company reported a GAAP EPS of -$0.23, which missed analyst estimates by $0.05, and a revenue of $3.86M, which beat by $0.11M.
Accelerate Diagnosti has been trading between a 52-week high of $7.19 and a 52-week low of $0.502. The stock has a market cap of $280 Million.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections.
As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:Guaires - 1 upvotes -
source$AXDX 🚀🌗💎